Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 10148184

New developments in electrotherapy.

V H Sinkus
View original source ↗Export metadata ↓

Abstract

In the last decade, and especially in the last five years, there has been a proliferation of new electrotherapy devices on the physical therapy market. As therapists, we have looked for other modalities to enhance our ability to help our patients. We have also seen PTs develop innovative treatment approaches, using these devices for pain relief, edema control, wound healing, and enhancement of muscle contractility. The following is a brief overview of some innovative electrotherapy approaches being used by PTs.

Explore related subjects

AnalgesiaElectric Stimulation TherapyEvaluation Studies as TopicHumansWound HealingJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

V H Sinkus. New developments in electrotherapy.. https://pubmed.ncbi.nlm.nih.gov/10148184/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2001

Influence of degradation on binding properties and biological activity of endomorphin 1.

The recently-isolated endogenous peptide endomorphin 1 has high affinity for the mu opioid receptor and plays an important role in analgesia. Several of its degradation products have been isolated from the central nervous system. Degradation products present structural similarities and may influence the receptor binding properties and biological activity of the parent compound. Therefore, we investigated how degradation of endomorphin 1 might influence ligand binding to the mu opioid receptor, the consequent activation of G proteins and its antinociceptive effect. Both N- and C-terminal truncation of endomorphin 1 resulted in peptides presenting considerably lower opioid receptor binding potency. None of these peptides had an effect on GTP binding, nor was able to produce analgesia, suggesting that degradation destroys the biological activity of endomorphin 1.

Analgesia↗
PubMed2001

Opioid neurotransmission in the post-ictal analgesia: involvement of mu(1)-opioid receptor.

Pentylenetetrazol (PTZ), a non-competitive antagonist that blocks GABA-mediated Cl(-) flux, was used in the present work to induce seizures in animals. The aim of this work is to study the neurochemical basis of the antinociception induced by convulsions elicited by peripheral administration of PTZ (64 mg/kg). The analgesia was measured by the tail-flick test, in eight rats per group. Convulsions were followed by significative increase in the tail-flick latencies (TFL), for at least 120 min of the post-ictal period. Peripheral administration of naltrexone (5 mg/kg, 10 mg/kg and 20 mg/kg) caused a significant decrease in the TFL in seizing animals, as compared to controls. These data were corroborated with peripheral administration of naloxonazine (10 mg/kg and 20 mg/kg), a mu(1)-opioid blocker, in the same doses used for non-specific antagonist. These results indicate that endogenous opioids may be involved in the post-ictal analgesia. The involvement of mu(1)-opioid receptor was also considered.

Analgesia↗